What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

His Tag Protein Purification: Principles and Protocols

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to His Tag Protein Purification

Recombinant protein production is a cornerstone of modern molecular biology, enabling the isolation of individual proteins for structural, biochemical, and therapeutic applications. Among the myriad of purification strategies available, the polyhistidine tag—commonly referred to as the His tag—has become the most widely used affinity handle for protein purification. Its popularity stems from a combination of small size, high selectivity, and the ability to function under both native and denaturing conditions.

What is a His Tag?

A His tag is a short amino acid sequence consisting of consecutive histidine residues, typically six to ten in number, genetically fused to either the N-terminus or C-terminus of a target protein. The tag exploits the intrinsic coordination chemistry of histidine: the imidazole side chain of this amino acid acts as a strong electron donor that can coordinate with transition metal ions such as nickel (Ni²⁺), cobalt (Co²⁺), copper (Cu²⁺), or zinc (Zn²⁺). When a recombinant protein bearing this tag is passed over a resin derivatized with immobilized metal ions, the histidine residues form stable coordination bonds with the metal, retaining the protein on the column while untagged contaminants flow through.

The standard His tag is six histidines (His₆), which provides sufficient binding affinity for most applications. Longer tags, such as His₈ or His₁₀, offer increased binding avidity and are sometimes used for proteins that are poorly expressed or difficult to solubilize. The tag is genetically encoded, meaning it is added at the DNA level during cloning, and it is expressed as part of the fusion protein.

Why Use His Tag Purification?

His tag purification offers several distinct advantages over other affinity purification methods. First, the tag is small—approximately 0.8 kDa for a His₆ tag—which minimizes the likelihood of interfering with protein folding, function, or crystallization. In contrast, larger tags such as glutathione S-transferase (GST, ~26 kDa) or maltose-binding protein (MBP, ~42 kDa) can substantially alter the biophysical properties of the fusion partner.

Second, the interaction between histidine and immobilized metal ions is reversible and can be controlled precisely by adjusting the concentration of imidazole, a structural analog of the histidine side chain. This allows for gentle elution conditions that preserve protein activity. Third, the purification works under a wide range of buffer conditions, including high salt concentrations, the presence of detergents, reducing agents, and even chaotropic agents such as 6 M guanidine hydrochloride or 8 M urea. This versatility makes His tag purification uniquely suited for membrane proteins and inclusion body proteins that require denaturing conditions for solubilization.

Finally, the resins are inexpensive, reusable, and available in a variety of formats, from bulk agarose to magnetic beads and pre-packed columns, making the method scalable from microgram to gram quantities. For a broader perspective on how His tag purification fits into the overall workflow of recombinant protein production, see Protein Expression and Purification.

Principle of Immobilized Metal Affinity Chromatography

Immobilized metal affinity chromatography (IMAC) is the technical foundation of His tag protein purification. The method was first described in 1975 by Porath and colleagues, who demonstrated that proteins with an affinity for metal ions could be retained on chelating resins loaded with transition metals. The selectivity of IMAC for histidine-rich proteins arises from the coordination chemistry between the imidazole nitrogen and the metal ion.

Coordination Chemistry of Histidine and Metal Ions

The imidazole side chain of histidine contains two nitrogen atoms: N1 (pyridine-type) and N3 (pyrrole-type). The N1 nitrogen, which is not protonated at physiological pH, possesses a lone pair of electrons that can coordinate with transition metal ions. In a His tag, the consecutive histidine residues present multiple imidazole rings in close proximity, creating a high local concentration of electron-donating groups. This arrangement allows for multidentate coordination—multiple imidazole groups binding to a single metal ion—which dramatically increases the stability of the protein–metal interaction.

The metal ion itself is immobilized on the chromatography resin through a chelating ligand. The most common chelators are nitrilotriacetic acid (NTA) and iminodiacetic acid (IDA). NTA is a tetradentate chelator, meaning it occupies four of the six coordination sites of the metal ion, leaving two sites available for interaction with histidine residues. IDA is a tridentate chelator, leaving three coordination sites available. The choice of chelator affects both the binding affinity and the metal leaching rate, as discussed in the next section.

The strength of the histidine–metal interaction depends on the metal ion. The affinity series for imidazole binding is generally Cu²⁺ > Ni²⁺ > Zn²⁺ > Co²⁺. Copper binds histidine too tightly, making elution difficult and often causing protein damage. Nickel and cobalt are the most commonly used metals for preparative purification, offering a balance between binding strength and ease of elution.

Role of Imidazole in Binding and Elution

Imidazole (C₃H₄N₂) is a heterocyclic compound that mimics the side chain of histidine. It competes with histidine residues for coordination sites on the immobilized metal ion. At low concentrations (typically 10–20 mM), imidazole is included in binding and wash buffers to reduce non-specific binding of host proteins that contain surface-exposed histidine residues. These contaminants typically interact with the metal ion through a single histidine or a pair of histidines, resulting in weaker binding than that of a polyhistidine tag. Low concentrations of imidazole therefore displace weakly bound contaminants while allowing the His-tagged protein to remain bound.

Elution is achieved by increasing the imidazole concentration to 200–500 mM. At these concentrations, imidazole outcompetes the histidine residues of the tag for metal coordination, displacing the target protein from the resin. The exact concentration required for elution depends on the length of the His tag, the metal ion used, and the density of the metal on the resin. A His₁₀ tag, for example, requires higher imidazole concentrations for elution than a His₆ tag because of the increased avidity of the longer tag.

Choosing the Right Resin and Metal Ion

The choice of resin and metal ion is a critical decision that affects yield, purity, and the overall success of the purification. Several commercial options are available, each with distinct properties. A detailed comparison of commercially available resins can be found in the His-tag Purification Resin resource.

Ni-NTA vs. Co-IDA

Nickel-nitrilotriacetic acid (Ni-NTA) is the most widely used IMAC resin. NTA forms a stable complex with Ni²⁺, with a binding constant of approximately 10⁻¹¹ M, which minimizes metal leaching during purification. Ni-NTA offers high binding capacity, typically 5–10 mg of His-tagged protein per milliliter of resin, and binds His₆-tagged proteins with a dissociation constant (Kd) in the low micromolar range.

Cobalt-based resins, most commonly cobalt-IDA (Co-IDA), offer higher selectivity at the cost of binding affinity. Co²⁺ coordinates histidine less strongly than Ni²⁺, which means that non-specific contaminants—particularly host proteins with surface histidines—bind less avidly. The result is higher purity in a single step, but with a lower binding capacity (typically 2–5 mg/mL) and a requirement for lower imidazole concentrations during elution. Co-IDA resins are often preferred when purity is more important than yield, or when the target protein is expressed at high levels and binding capacity is not limiting.

The following table summarizes the key differences:

Property	Ni-NTA	Co-IDA
Chelator	Nitrilotriacetic acid (tetradentate)	Iminodiacetic acid (tridentate)
Metal coordination sites available	2	3
Binding affinity for His₆ tag	High (Kd ~10⁻⁶ M)	Moderate (Kd ~10⁻⁵ M)
Binding capacity	5–10 mg/mL resin	2–5 mg/mL resin
Selectivity	Moderate	High
Imidazole concentration for elution	200–300 mM	100–200 mM
Metal leaching	Low	Moderate
Typical use	High-yield purification	High-purity purification

Resin Formats: Agarose, Magnetic Beads, and Others

IMAC resins are available in several physical formats, each suited to different applications. Agarose beads (typically 4% or 6% cross-linked) are the traditional format for gravity-flow columns and low-pressure FPLC systems. They offer high binding capacity and are inexpensive, but require centrifugation or column packing for separation.

Magnetic beads, typically 1–5 µm in diameter with an iron oxide core, allow for rapid separation using a magnetic stand. This format is ideal for small-scale purifications, parallel processing in multi-well plates, and automated systems. Magnetic beads have a lower binding capacity than agarose resins but offer faster binding kinetics due to the small bead size and the ability to mix the suspension thoroughly.

Pre-packed columns, such as 1 mL or 5 mL HisTrap columns, are designed for use with FPLC systems and offer reproducibility and ease of use. These columns are pre-equilibrated and can be regenerated multiple times. For high-throughput applications, 96-well filter plates pre-loaded with IMAC resin are available, enabling parallel purification of many samples. The choice of format should be guided by the scale of purification, the downstream application, and the available equipment.

Vector Design and His Tag Placement

The position of the His tag within the recombinant protein can significantly affect expression levels, solubility, and the functionality of the purified protein. The tag can be placed at either the N-terminus or the C-terminus, and the choice should be made based on the structural and biophysical properties of the target protein.

N-Terminal vs. C-Terminal Tags

An N-terminal His tag is the most common configuration. During translation, the tag is synthesized first and is therefore exposed on the surface of the nascent polypeptide, allowing it to fold independently of the rest of the protein. N-terminal tags are generally well tolerated and rarely interfere with protein folding. However, they can affect the cleavage of the N-terminal methionine by methionine aminopeptidase, potentially altering the N-terminal amino acid of the mature protein. This can be problematic for proteins that require a specific N-terminal residue for activity or for downstream applications such as protein sequencing.

A C-terminal His tag is advantageous when the N-terminus of the protein is structurally or functionally important—for example, when the N-terminus is buried in the protein core or participates in ligand binding. C-terminal tags are also useful for proteins expressed as fusions with an N-terminal signal peptide, which is cleaved during secretion; in this case, the C-terminal tag remains attached to the mature protein. However, C-terminal tags are only fully translated after the entire protein has been synthesized, which means that if translation is prematurely terminated, truncated proteins lacking the tag will be produced. This can complicate purification if the truncated species co-purifies with the full-length protein.

In some cases, dual tagging—with a His tag at both termini—is used to ensure that only full-length proteins are purified. This strategy is particularly useful for proteins prone to proteolytic degradation or for those expressed in systems with high rates of premature translation termination.

Cleavable Tags and Protease Sites

Although the His tag is small, it can still interfere with protein function, crystallization, or structural studies. For applications where the tag must be removed, a protease cleavage site is inserted between the tag and the target protein. The most commonly used proteases are tobacco etch virus (TEV) protease, which recognizes the sequence ENLYFQG and cleaves between Q and G; PreScission protease (human rhinovirus 3C protease), which recognizes LEVLFQGP; and thrombin, which recognizes LVPRGS.

TEV protease is generally preferred because it is highly sequence-specific, active at 4°C, and can be easily removed after cleavage using a second IMAC step. The protease itself is often His-tagged, allowing it to bind to the resin along with the cleaved His tag while the untagged target protein flows through. This "reverse IMAC" strategy is a convenient way to obtain tag-free protein in a single additional step. For a more detailed discussion of tag removal strategies and their implications, see His Tagged Protein Purification.

The linker sequence between the tag and the protease site should be flexible to ensure accessibility. A common design is His₆-Gly-Ser-Ser-Gly-ENLYFQG-target protein. The glycine and serine residues provide conformational flexibility, allowing the protease to access its recognition site without steric hindrance from the folded protein.

Step-by-Step Purification Protocol

The following protocol describes a standard His tag purification under native conditions. All steps should be performed at 4°C unless otherwise noted, to minimize proteolysis and preserve protein activity.

Cell Lysis and Clarification

Harvest cells. Pellet the expression culture by centrifugation at 4,000–6,000 × g for 15 minutes at 4°C. Discard the supernatant and resuspend the cell pellet in lysis buffer at a ratio of 5–10 mL of buffer per gram of wet cell paste.

Lysis buffer composition: 50 mM sodium phosphate (pH 8.0), 300 mM NaCl, 10 mM imidazole, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 1× protease inhibitor cocktail (e.g., cOmplete EDTA-free). Optionally, add 1 mg/mL lysozyme and 10 µg/mL DNase I to facilitate lysis and reduce viscosity.

Lyse the cells. The method of lysis depends on the scale and the equipment available. For small volumes (<10 mL), sonication on ice using a probe sonicator (6 × 10-second pulses at 30% amplitude with 30-second cooling intervals) is effective. For larger volumes, use a French press (1,000–1,500 psi) or an EmulsiFlex high-pressure homogenizer. Alternatively, chemical lysis using 0.1% Triton X-100 or 1% CHAPS in the lysis buffer can be used for cells that are easily lysed.

Clarify the lysate. Centrifuge the lysate at 20,000–30,000 × g for 30 minutes at 4°C to remove cell debris and insoluble material. Filter the supernatant through a 0.45 µm syringe filter to remove any remaining particulate matter. The clarified lysate is now ready for loading onto the IMAC column.

Binding and Washing Conditions

Equilibrate the resin. For gravity-flow columns, add the appropriate volume of Ni-NTA agarose (typically 1 mL of resin per 5–10 mg of target protein) to a disposable column and allow the storage buffer to drain. Equilibrate the resin with 10 column volumes (CV) of lysis buffer (without PMSF and protease inhibitors).

Load the clarified lysate. Apply the clarified lysate to the column and collect the flow-through. For maximum binding, the flow-through can be reapplied to the column once or twice. Alternatively, perform batch binding by incubating the lysate with the resin in a 50 mL conical tube on a rotator for 30–60 minutes at 4°C, then transfer the mixture to the column.

Wash the column. Wash the resin with 10–20 CV of wash buffer to remove non-specifically bound proteins.

Wash buffer composition: 50 mM sodium phosphate (pH 8.0), 300 mM NaCl, 20–40 mM imidazole.

The imidazole concentration in the wash buffer should be optimized for each protein (see the Optimization section below). Collect the wash fractions for analysis.

Elution Strategies

Elute the target protein. Elute the His-tagged protein by applying elution buffer containing a high concentration of imidazole.

Elution buffer composition: 50 mM sodium phosphate (pH 8.0), 300 mM NaCl, 250–500 mM imidazole.

Collect fractions of 0.5–1 CV each. For a step elution, apply 5 CV of elution buffer and collect the entire eluate as one fraction. For a gradient elution, use an FPLC system to apply a linear gradient from 20 mM to 500 mM imidazole over 10–20 CV, collecting 1–2 mL fractions. Gradient elution often yields better separation of the target protein from contaminants that bind with intermediate affinity.

Analyze the fractions. Assess the purity and yield of the eluted fractions by SDS-PAGE. Pool the fractions containing the target protein at acceptable purity. If the protein will be used for downstream applications requiring high purity, proceed to a polishing step such as size-exclusion chromatography or ion-exchange chromatography. For guidance on quantifying the purified protein, see __MASK_4__.

Regenerate the resin. After use, wash the resin with 5 CV of 0.5 M NaOH or 6 M guanidine hydrochloride to remove tightly bound contaminants, followed by 10 CV of deionized water and 5 CV of 20% ethanol for storage at 4°C.

Optimization of Binding and Elution Conditions

The standard protocol described above provides a starting point, but optimal conditions vary from protein to protein. Systematic optimization of imidazole concentration, pH, and salt concentration can substantially improve both yield and purity.

Imidazole Titration

The concentration of imidazole in the binding and wash buffers is the single most important parameter to optimize. Too little imidazole results in excessive non-specific binding of host proteins; too much imidazole reduces the binding of the target protein, leading to low yield.

A simple titration experiment can determine the optimal imidazole concentration. Prepare a series of wash buffers containing 10, 20, 30, 40, 50, and 60 mM imidazole. Load identical aliquots of clarified lysate onto separate small columns (100 µL resin each), wash with 10 CV of each buffer, and elute with 500 mM imidazole. Analyze the eluates by SDS-PAGE. The optimal wash concentration is the highest imidazole concentration that does not elute the target protein but effectively removes contaminants.

For elution, determine the minimum imidazole concentration required to release the target protein. Elute with stepwise increases in imidazole (e.g., 50, 100, 150, 200, 250, 300, 400, 500 mM) and analyze the fractions. Using the lowest effective imidazole concentration for elution reduces the amount of imidazole that must be removed by dialysis or buffer exchange in subsequent steps.

Effect of pH and Salt

The coordination of histidine to Ni²⁺ is pH-dependent. The imidazole nitrogen must be deprotonated to coordinate with the metal ion; the pKa of the imidazole side chain is approximately 6.0. At pH values below 7.0, a significant fraction of histidine residues are protonated and cannot bind. Binding is therefore typically performed at pH 7.5–8.0, where the imidazole groups are predominantly deprotonated.

Elution can also be achieved by lowering the pH, since protonation of the histidine residues disrupts metal coordination. A pH gradient from 8.0 to 4.0 can be used as an alternative to imidazole elution. This approach is sometimes preferred for proteins that are sensitive to high imidazole concentrations, although the low pH conditions may cause protein precipitation.

Salt concentration affects both binding specificity and protein solubility. A moderate salt concentration (300–500 mM NaCl) reduces non-specific ionic interactions between the resin and contaminating proteins. However, very high salt concentrations (>1 M) can weaken the histidine–metal interaction by competing for coordination sites. For proteins that require high salt for solubility, 500 mM NaCl is a reasonable compromise. In some cases, the inclusion of 1–2% glycerol or 0.1% detergent (e.g., Triton X-100 or CHAPS) in the buffers can improve protein stability and reduce aggregation.

Troubleshooting Common Problems

Despite the simplicity of His tag purification, several recurring problems can compromise the outcome. The following section addresses the most common issues and their solutions.

Low Yield or No Binding

If the target protein does not bind to the resin, consider the following possibilities:

The His tag is not accessible. The tag may be buried in the folded protein structure. This is more common with C-terminal tags. Try denaturing conditions (8 M urea or 6 M guanidine hydrochloride) to expose the tag, or switch to an N-terminal tag.
The imidazole concentration in the binding buffer is too high. Reduce the imidazole concentration to 5 mM or eliminate it entirely during binding.
The pH is too low. Ensure the binding buffer is at pH 7.5–8.0.
The metal ion has leached from the resin. This can occur with IDA-based resins or after repeated use. Reload the resin with fresh metal ion (100 mM NiSO₄ or CoCl₂) and re-equilibrate.
The protein is expressed at very low levels. Check expression by SDS-PAGE of the total lysate. If expression is low, consider optimizing expression conditions or using a stronger promoter.
The protein is insoluble. If the protein is in the pellet fraction after centrifugation, it is likely in inclusion bodies. Solubilize the pellet in 8 M urea or 6 M guanidine hydrochloride and purify under denaturing conditions.

Contaminating Proteins

Non-specific binding of host proteins is the most common purity problem. Host proteins with surface-exposed histidine residues, particularly those from E. coli, can bind to IMAC resins. Solutions include:

Increase the imidazole concentration in the wash buffer. Titrate from 20 mM up to 60 mM to find the optimal concentration.
Increase the salt concentration. Raising NaCl to 500 mM reduces ionic interactions.
Switch to a cobalt resin. Co-IDA has higher selectivity than Ni-NTA.
Add a low concentration of a mild detergent (e.g., 0.1% Triton X-100) to the wash buffer to disrupt hydrophobic interactions.
Perform a second purification step. Size-exclusion chromatography or ion-exchange chromatography can remove residual contaminants. For high-purity applications, consider a two-step strategy as described in Custom Protein Purification.

Protein Insolubility and Aggregation

If the target protein precipitates during purification, the following adjustments may help:

Lower the protein concentration. Elute in a larger volume or use a shallower gradient to keep the protein concentration below its aggregation threshold.
Add stabilizing agents. Include 5–10% glycerol, 0.5–1 M arginine, or 0.1% detergent in the buffers.
Reduce the temperature. Perform the purification at 4°C.
Elute with a pH gradient instead of imidazole. Some proteins precipitate in the presence of high imidazole concentrations.
Purify under denaturing conditions. If the protein is prone to aggregation, purify in 8 M urea and refold the protein after elution. For a detailed discussion of denaturing purification and refolding, see the FAQ section below.

Scale-Up and High-Throughput Considerations

The transition from small-scale to large-scale purification requires attention to binding capacity, flow rate, and buffer volumes. Conversely, high-throughput applications demand miniaturization and parallelization.

Batch vs. Column Purification

For small-scale purifications (up to a few milligrams of protein), gravity-flow columns are simple and effective. For larger scales, batch binding is often more efficient. In batch mode, the clarified lysate is incubated with the resin in a stirred vessel or on a rotator for 30–60 minutes, allowing the target protein to bind to the resin. The resin is then collected by centrifugation or filtration, washed, and eluted. Batch binding is particularly useful when the lysate volume is large, as it avoids the slow flow rates associated with column chromatography.

For preparative scale purification (tens to hundreds of milligrams), an FPLC system with a pre-packed column is recommended. The column can be operated at higher flow rates (1–5 mL/min for a 5 mL column) with precise gradient control. Scale-up is generally linear: a 5 mL column can purify 25–50 mg of protein, while a 50 mL column can purify 250–500 mg.

Automation and Multi-Well Formats

For screening applications—such as testing multiple expression constructs, mutants, or buffer conditions—automated purification in 96-well filter plates is a powerful approach. Each well contains a small amount of resin (20–50 µL), and the entire purification is performed using a vacuum manifold or a liquid-handling robot. This format allows for the parallel processing of 96 samples in under two hours.

Automated FPLC systems can also be programmed to perform sequential purifications with minimal user intervention. For laboratories that routinely purify many different proteins, the investment in an automated system can substantially increase throughput. The integration of purification with downstream quantification is discussed in Protein Quantification Mass Spectrometry, which is particularly relevant for high-throughput workflows.

Common Pitfalls and Best Practices

Even experienced researchers can encounter difficulties with His tag purification. The following best practices will help avoid the most common pitfalls.

Avoiding Protease Contamination

Proteolytic degradation is a leading cause of low yield and the appearance of truncated products. To minimize proteolysis:

Use protease inhibitors. Include a broad-spectrum protease inhibitor cocktail (e.g., cOmplete EDTA-free) in the lysis buffer. PMSF (1 mM) is effective against serine proteases but has a short half-life in aqueous solution; add it fresh.
Work at 4°C. All steps should be performed on ice or in a cold room.
Minimize the time between lysis and purification. Process the lysate as quickly as possible.
Use protease-deficient expression strains. E. coli strains such as BL21(DE3) are deficient in Lon and OmpT proteases.

Ensuring Proper Equilibration

Failure to equilibrate the resin properly can lead to poor binding and low yield. Always equilibrate with at least 10 CV of binding buffer before loading the sample. The pH and salt concentration of the equilibration buffer should match the lysate conditions. If the lysate contains high concentrations of imidazole or other additives, adjust the binding buffer accordingly.

Storage of Resins and Buffers

IMAC resins should be stored as a slurry in 20% ethanol at 4°C to prevent microbial growth. Before use, wash the resin with deionized water to remove the ethanol. After use, regenerate the resin by stripping the metal with 50 mM EDTA, washing with water, reloading with fresh metal (100 mM NiSO₄ or CoCl₂), and re-equilibrating with binding buffer. Resins can typically be reused 5–10 times before binding capacity declines.

Buffers should be prepared fresh or stored at 4°C for no more than a few days. Imidazole-containing buffers are particularly prone to microbial contamination. Filter all buffers through a 0.22 µm filter before use.

Frequently Asked Questions

What is the principle behind his tag protein purification?

His tag purification relies on the coordination chemistry between the imidazole side chains of consecutive histidine residues and immobilized transition metal ions, typically Ni²⁺ or Co²⁺. The metal ions are chelated to a resin through ligands such as NTA or IDA. The His-tagged protein binds to the metal ions through multidentate coordination, while untagged proteins do not. Elution is achieved by adding imidazole, which competes with the histidine residues for metal coordination, or by lowering the pH, which protonates the imidazole groups and disrupts binding.

How do I write a his tag protein purification protocol?

A standard protocol should include the following sections: (1) cell lysis, with the lysis buffer composition and lysis method; (2) clarification by centrifugation and filtration; (3) resin equilibration; (4) binding, either by column loading or batch incubation; (5) washing with buffer containing low imidazole; (6) elution with buffer containing high imidazole; and (7) analysis of fractions by SDS-PAGE. Include the exact buffer compositions, volumes, and temperatures. For a template, see the step-by-step protocol in this article.

Why is my his tag protein not binding to the resin?

Common causes include: the His tag is not accessible on the protein surface; the imidazole concentration in the binding buffer is too high; the pH is below 7.0; the metal ion has leached from the resin; the protein is insoluble and present in the pellet fraction; or the protein is expressed at very low levels. Troubleshoot by checking each of these parameters systematically.

What is the procedure for his tag protein purification?

The procedure involves: (1) expressing the His-tagged protein in a suitable host; (2) lysing the cells and clarifying the lysate; (3) binding the clarified lysate to an IMAC resin pre-equilibrated with binding buffer; (4) washing the resin with buffer containing low imidazole (10–40 mM) to remove contaminants; (5) eluting the target protein with buffer containing high imidazole (200–500 mM); and (6) analyzing the fractions by SDS-PAGE and pooling the pure fractions.

How do I troubleshoot his tag protein purification problems?

Approach troubleshooting systematically. For low yield, check tag accessibility, binding buffer composition, pH, and metal loading. For poor purity, increase the imidazole concentration in the wash buffer, increase salt, or switch to a cobalt resin. For protein precipitation, add glycerol or detergent, reduce the protein concentration, or purify under denaturing conditions. Always analyze every fraction by SDS-PAGE to identify where the problem occurs.

What is the difference between Ni-NTA and cobalt resin for his tag purification?

Ni-NTA has a higher binding affinity and capacity but lower selectivity, resulting in more non-specific binding. Cobalt resins (Co-IDA) have lower affinity and capacity but higher selectivity, yielding purer protein in a single step. Ni-NTA is preferred for high-yield purification, while cobalt is preferred when purity is critical or when the target protein is expressed at high levels.

Can I purify his tag protein under denaturing conditions?

Yes. His tag purification works well under denaturing conditions using 8 M urea or 6 M guanidine hydrochloride. The imidazole–metal interaction is not dependent on protein folding, so the tag remains accessible even when the protein is denatured. After purification, the protein can be refolded by dialysis against a buffer without denaturant, often with the addition of reducing agents such as 1 mM dithiothreitol (DTT) or β-mercaptoethanol. Refolding conditions must be optimized for each protein.

How do I remove the his tag after purification?

The His tag can be removed by engineering a protease cleavage site between the tag and the target protein. After purification, incubate the eluted protein with the appropriate protease (e.g., TEV protease at a 1:50 to 1:100 protease-to-protein ratio) at 4°C for 12–16 hours. Then pass the cleavage reaction over the IMAC resin again; the His-tagged protease and the cleaved His tag bind to the resin, while the untagged target protein flows through. For applications requiring the highest purity, follow with a polishing step such as size-exclusion chromatography. For more details on this workflow, see His Tag Labeling Purification.

Key Takeaways

His tag purification exploits the coordination of consecutive histidine residues to immobilized Ni²⁺ or Co²⁺ ions, providing a simple, reversible, and versatile affinity method.
Ni-NTA offers higher binding capacity and affinity, while Co-IDA provides higher selectivity; the choice depends on whether yield or purity is the priority.
The position of the His tag (N-terminal vs. C-terminal) and the inclusion of a protease cleavage site should be carefully considered during vector design.
Imidazole concentration, pH, and salt are the three key variables for optimizing binding specificity and elution efficiency.
Common problems—low yield, contamination, and aggregation—can usually be resolved by systematic titration of imidazole, adjustment of buffer composition, or switching between nickel and cobalt resins.
The method is scalable from 96-well plate formats to preparative columns, and it works under both native and denaturing conditions.
Always analyze fractions by SDS-PAGE and consider a polishing step for applications requiring high purity, such as structural studies or therapeutic protein production.